Pulmonary Pleomorphic Carcinoma Harboring EGFR Mutation Successfully Treated with Osimertinib: A Case Report

Pulmonary Pleomorphic Carcinoma Harboring EGFR Mutation Successfully Treated with Osimertinib: A Case Report

Pulmonary pleomorphic carcinoma (PPC) is well-known for its aggressive nature that is usually resistant to platinum-based chemotherapy. On the other hand, the efficacy of an immune checkpoint inhibitor-based regimen in PPC has been elucidated. PPCs harboring epidermal growth factor receptor (EGFR) m...

Full description

Bibliographic Details
Main Authors: Yukari Kano, Nobutaka Kataoka, Yusuke Kunimatsu, Rei Tsutsumi, Izumi Sato, Mai Tanimura, Takayuki Nakano, Keiko Tanimura, Takayuki Takeda
Format: Article
Language:English
Published: MDPI AG 2022-05-01
Series:Medicina
Subjects:
brain metastasis
carcinomatous pericarditis
epidermal growth factor receptor
osimertinib
pulmonary pleomorphic carcinoma
Online Access:https://www.mdpi.com/1648-9144/58/6/706

Internet

https://www.mdpi.com/1648-9144/58/6/706

Similar Items